Document Type
Patent
Publication Date
November 2013
Patent Number
8592368
Abstract
The present invention concerns a method for treating or reducing the likelihood of developing a respiratory syncytial virus (RSV) infection in a subject by administering an effective amount of an inhibitor of the janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway or the mitogen-activated kinase (MAPK)/extracellular signal-regulated kinase (ERK1/2) signaling pathway to the subject. Another aspect of the invention concerns a pharmaceutical composition that includes an inhibitor of JAK/STAT or MAPK/ERK signaling to the subject; and a pharmaceutically acceptable carrier. Another aspect of the invention concerns a method for identifying agents useful for treating or reducing the likelihood of developing an RSV infection.
Application Number
11/018,954
Recommended Citation
Mohapatra, Shyam S., "JAK/STAT inhibitors and MAPK/ERK inhibitors for RSV infection" (2013). USF Patents. 266.
https://digitalcommons.usf.edu/usf_patents/266
Assignees
University of South Florida
Filing Date
12/20/2004
Primary/U.S. Class
514/37
